Fatty liver and ischemia/reperfusion: Are there drugs able to mitigate injury

Current Medicinal Chemistry

Volumn 18, Issue 32, 2011, Pages 4987-5002

  Varela, Ana T ^a,b   Rolo, Anabela P ^a,c   Palmeira, Carlos M ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

ATP; Cell death; Compounds; Fatty liver; Ischemia reperfusion; Mitochondria; Mitochondrial permeability transition; Oxidative stress; Preconditioning

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE A2A RECEPTOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANGIOTENSIN RECEPTOR; CAPTOPRIL; CYCLOPHILIN D; DIAZOXIDE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDIRUBIN; INDIRUBIN 3' OXIME; LOSARTAN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; S NITROSOTHIOL; SIRTUIN 3; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY BALANCE; ENERGY METABOLISM; FATTY LIVER; HUMAN; ISCHEMIA; ISCHEMIC PRECONDITIONING; KUPFFER CELL; LEUKOCYTE; LIVER INJURY; MICROCIRCULATION; MITOCHONDRION; NONHUMAN; PROTEIN DEPLETION; REPERFUSION;

FATTY LIVER; HUMANS; ISCHEMIC PRECONDITIONING; REPERFUSION INJURY;

EID: 80054860029     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797535164     Document Type: Article

References (231)

1. Behrns, K. E.; Tsiotos, G. G.; DeSouza, N. F.; Krishna, M. K.; Ludwig J.; Nagorney, D. M. Hepatic steatosis as a potential risk factor for major hepatic resection. J. Gastrointest Surg., 1998, 2, 292-298. (Pubitemid 128409616)
2. Canelo, R.; Braun, F.; Sattler, B.; Klinge, B.; Lorf, T.; Ramadori, G.; et al. Is a fatty liver dangerous for transplantation? Transplant Proc., 1999, 31, 414-415. (Pubitemid 29127509)
3. D'Alessandro, A. M.; Kalayoglu, M.; Sollinger, H. W.; Hoffmann, R. M.; Reed, A.; Knechtle, S. J.; et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation, 1991, 51, 157-163.
4. He, S.; Atkinson, C.; Evans, Z.; Ellett, J. D.; Southwood, M.; Elvington, A.; Chavin, K. D.; Tomlinson, S. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury. J. Immunol. , 2009, 183(7), 4764-72.
5. Degle Esposti, D.; Sebagh, M.; Pham, P.; Reffas, M.; Pous, C.; Azzoulay, D.; Lemoine, A. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis., 2011.
6. Fan, C.; Zwacka, R. M.; Engelhardt, J. F. Therapeutic approaches for ischemia/reperfusion injury in the liver. Journal of Molecular Medicine, 1999, 77(8), 577-592. (Pubitemid 29479979)
7. Banga, N. R.; Homer-Vanniasinkam, S.; Graham, A.; Al-Mukhtar, A.; White, S. A.; Prasad, K. R. Ischaemic preconditioning in transplantation and major resection of the liver. British Journal of Surgery, 2005, 92 (5), 528-538. (Pubitemid 40685646)
8. Jaeschke, H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. American Journal of Physiology: Gastrointestinal and Liver Physiology, 2003, 284 (1), G15-G26. (Pubitemid 36076246)
9. Fukumori, T.; Ohkohchi, N.; Tsukamoto, S.; Satomi, S. Why is fatty liver unsuitable for transplantation? Disorientation of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transpl. Proc., 1997, 29, 412-415. (Pubitemid 27123465)
10. Selzner, M.; Rüdiger, H.; Sindram, D.; Maddan, J.; Clavien, P. A. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology, 2000, 32, 1280-1288.
11. Teramoto, K.; Bowers, J.; Kruskal, J.; Clouse, M. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation, 1993, 56, 1076-1082. (Pubitemid 23348677)
12. Caraceni, P.; Domenicali, M.; Vendemiale, G.; Grattagliano, I.; Pertosa, A.; Nardo, B.; et al. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J. Surg. Res., 2005, 124, 160-168. (Pubitemid 40463713)
13. Rolo, A. P.; Teodoro, J. S.; Peralta, C.; Rosello-Catafau, J.; Palmeira, C. M. Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: The key role of ATPsynthase and mitochondrial permeability transition. Transpl. Int., 2009, 22(11), 1081-90.
14. Jassem, W.; Fuggle, S. V.; Rela, M.; Koo, D. D.; Heaton, N. D. The role of mitochondria in ischemia/reperfusion injury. Transplantation. , 2002, 27; 73(4), 493-9. (Pubitemid 34193605)
15. Orrenius, S.; McConkey, D. J.; Bellomo, G.; Nicotera, P. Role of Ca in toxic cell injury. TIPS, 1989, 10, 281-285.
16. Jennings, R. B.; Reimer, K. A. The cell biology of acute myocardial ischemia. Annu. Rev. Med., 1991, 42, 225-246.
17. Green, D. R.; Reed, J. C. Mitochondria and apoptosis. Science. , 1998, 28, 281(5381):1309-12. (Pubitemid 28406816)
18. Anderson, C. D.; Pierce, J.; Nicoud, I.; Belous, A.; Knox, C. D.; Chari, R. S. Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury. Liver Transpl. , 2005, 11(6), 663-8. (Pubitemid 40872905)
19. Garcia-Dorado, D.; Rodriguez-Sinovas, A.; Ruiz-Meana, M.; Inserte, J.; Agullo, L.; Cabestrero, A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc. Res., 2006, 70, 274-285.
20. Haque, M.; Sanyal, A. The metabolic abnormalities associated with non alcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenlogy., 2002, 16, 709-731.
21. Browning, J. D.; Horton, J. D. Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest., 2004, 114, 147-152. (Pubitemid 39071617)
22. Johnson, E. F.; Palmer, C. N.; Griffin, K. J.; Hsu, M. H. Role of the peroxisome proliferator activated receptor in cytochrome P450 4A gene regulation. FASEB J., 1996, 10, 1241-1248. (Pubitemid 26307509)
23. Reddy, J. K.; Mannaerts, G. P. Peroxisomal lipid metabolism. Annu. Rev. Nutr., 1994, 114, 343-370. (Pubitemid 24261842)
24. Rachek L. I.; Yuzefovych L. V.; Ledoux S. P.; Julie N. L.; Wilson G. L. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes. Toxicol. Appl. Pharmacol., 2009, 240, 348-354.
25. Ricci, C.; Pastukh, V.; Leonard, J.; Turrens, J.; Wilson, G.; Schaffer, D.; Schaffer, S. W. Mitochondrial DNA damage triggers mitochondrialsuperoxide generation and apoptosis. Am. J. Physiol. Cell Physiol., 2008 , 294, C413-C422. (Pubitemid 351264418)
26. Petrosillo, G.; Portincasa, P.; Grattagliano, I.; Casanova, G.; Matera, M.; Ruggiero, F. M.; Ferri, D.; Paradies, G. Mitochondrial dysfunction in rat with nonalcoholic fatty liver. Involvemnt of complex I, reactive oxygen species and cardiolipin. Biochimica et Biophysica., 2007, Acta 1767, 1260-1267. (Pubitemid 47498313)
27. Cortez-Pinto, H.; Chatham, J.; Chacko, V. P.; Arnold, C.; Rashid, A.; Diehl, A. M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA., 1999, 282, 1659-1664. (Pubitemid 29513973)
28. Hensley, K.; Robinson, K. A.; Gabbita, S. P.; Salsman, S.; Floyd, R. A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med., 2000, 28, 1456-1462. (Pubitemid 30604227)
29. Pérez-Carreras, M.; Del Hoyo, P.; Martín, M. A.; Rubio, J. C.; Martín, A.; Castellano, G.; Colina, F.; Arenas, J.; Solis-Herruzo, J. A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology., 2003, 38, 999-1007. (Pubitemid 37221683)
30. Chavin, K. D.; Yang, S.; Lin, H. Z.; Chatham, J.; Chacko, V. P.; Hoek, J. B.; Walajtys-Rode, E.; Rashid, A.; Chen, C. H.; Huang, C. C.; Wu, T. C.; Lane, M. D.; Diehl, A. M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem., 1999, 274, 5692-5700. (Pubitemid 29109222)
31. Teodoro, J. S.; Rolo, A. P.; Duarte, F. V.; Simões, A. M.; Palmeira, C. M. Differential alterations in mitochondrial function induced by a cholinedeficient diet: Understanding fatty liver disease progression. Mitochondrion., 2008, 8, 367-376.
32. Teodoro, J.; Rolo, A. P.; Oliveira, P. J.; Palmeira, C. M. Decreased ANT content in Zucker fatty rats: Relevance for altered hepatic mitochondrial bioenergetics in steatosis. FEBS Lett., 2006, 580, 2153-2157.
33. Preiss, D.; Sattar, N. Non-alcoholic fatty liver disease: An overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 2008, 115, 141-150.
34. Kleiner, D. E.; Brunt, E. M.; Van Natta, M.; Behling, C.; Contos, M. J.; Cummings O. W.; Ferrell L. D.; Liu, Y. C.; Torbenson, M. S.; Unalp-Arida, A.; Yeh, M.; McCullough, A. J.; Sanyal, A. J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 2005, 41, 1313-1321. (Pubitemid 40770284)
35. Brunt, E. M.; Tiniakos, D. G. Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol. , 2010, 16(42), 5286-5296.
36. Teoh, N. C.; Farrel, G. C. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol Hepatol., 2003, 18(8), 891-902. (Pubitemid 37056167)
37. Jaeschke, H.; Farhood, A.; Smith, C. W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J., 1990, 4(15), 3355-9. (Pubitemid 120012584)
38. Jaeschke, H.; Smith C. V.; Mitchell J. R. Hypoxic damage generates reactive oxygen species in isolated perfused rat liver. Biochem. Biophys. Res. Commun., 1988, 150(2), 568-74.
39. Wanner, G. A.; Ertel, W.; Muller, P.; et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock., 1996, 5(1), 34-40. (Pubitemid 126729531)
40. Lentsch, A. B.; Yoshidome, H.; Kato, A.; et al. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology, 1999, 30(6), 1448-53.
41. Gosh, S.; May, M. J.; Koop, E. B. NF-Kb and Rel proteins: Evolucionary conserved mediators of immune responses. Annu. Rev. Imunol., 1998, 16, 225-60. (Pubitemid 28183365)
42. Lentsch, A. B.; Yoshidome, H.; Cheadle, W. G.; et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology, 1998, 27(4), 1172-7.
43. Jaeschke, H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chemico-Biological Interactions, 1991, 79 (2), 115-136.
44. Furukawa, H.; Todo, S.; Imventarza, O.; Casavilla, A.; Wu, Y. M.; Scotti-Foglieni, C.; Broznick, B.; Bryant, J.; Day, R.; Starzl, T. E. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation, 1991, 51, 1000-1004.
45. Ploeg, R. J.; D'Alessandro, A. M.; Hoffmann, R. M.; Eckhoff, D.; Isaacs, R.; Knechtle, S. J.; Pirsch, J. D.; Stegall, M. D.; Kalayoglu, M.; Belzer F. O. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant. Proc., 1993, 25, 3031-3033. (Pubitemid 24007211)
46. Porte, R. J.; Ploeg, R. J.; Hansen, B.; van Bockel, J. H.; Thorogood, J.; Persijn, G. G.; Hermans, J.; Terpstra, O. T. Long-term graft survival after liver transplantation in the UW era: Late effects of cold ischemia and primary dysfunction. Transpl. Int., 1998, 11, Suppl. 1, S164-S167. (Pubitemid 128683533)
47. Caldwell-Kenkel, J. C.; Currin, R. T.; Tanaka, Y.; et al. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology, 1991, 13(1), 83-95.
48. Gao, W.; Bentley, R. C.; Madden, J. F.; et al. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology, 1998, 27(6), 1652-1660. (Pubitemid 28264691)
49. Inserte, J.; Gacrcia-Dorado, D.; Hernando, V.; Barba, I.; Soler-Soler, J. Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion. Cardiovasc. Res., 2006, 70, 364-373. (Pubitemid 44316810)
50. Inserte, J.; Garcia-Dorado, D.; Ruiz-Meana, M.; Padilla, F.; Barrabe 's, J. A.; Pina, P.; et al. Effect of inhibition of Na+/Ca2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc. Res., 2002, 55, 739-748.
51. Murphy, E.; Steenbergen C. Ion transport and energetics during cell death and protection. Physiology (Bethesda) , 2008, 2, 115-123.
52. Farber, J. L. Membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis. Lab. Inves., 1982, 47, 114-123. (Pubitemid 12051534)
53. Schanne, F. A. X.; Kane, A. B.; Young, E. A.; Farber, J. L.; Calcium dependence of toxic cell death, a final common pathway. Science, 1979, 206, 700-702. (Pubitemid 10203221)
54. Jaeschke, H.; Mitchell J. R. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochemical and Biophysical Research Communications, 1989, 160 (1), 140-147. (Pubitemid 19116473)
55. Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol., 2003, 552, 335-344. (Pubitemid 37321833)
56. Becker, L. B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res., 2004, 61, 461-470. (Pubitemid 38210152)
57. Chen, Q.; Moghaddas, S.; Hoppel , C. L.; Lesnefsky, E. J. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. American Journal of Physiology Cell Physiology., 2008, 294, C460-C466. (Pubitemid 351276913)
58. Petrosillo, G.; Ruggiero, F. M.; Di Venosa, N.; Paradies, G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: Role of reactive oxygen species and cardiolipin. FASEB J., 2003, 17, U395-U413.
59. Paradies, G.; Petrosillo, G.; Pistolese, M.; Di Venosa, N.; Federici, A.; Ruggiero, F. M. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart-Involvement of reactive oxygen species and cardiolipin. Circ. Res., 2004, 94, 53-59. (Pubitemid 38064098)
60. Echtay, K. S.; Esteves, T. C.; Pakay, J. L.; Jekabsons, M. B.; Lambert, A. J.; Portero Otin, M.; Pamplona, R.; Vidal Puig, A. J.; Wang S.; Roebuck, S. J.; Brand, M. D. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J., 2003, 22, 4103-4110. (Pubitemid 37021739)
61. Hool, L. C. Reactive oxygen species in cardiac signalling: From mitochondria to plasma membrane ion channels. Clin. Exp. Pharmacol. Physiol., 2006, 33, 146-151.
62. Dhalla, N. S.; Elmoselhi, A. B.; Hata, T.; Makino, N. Status of myocardial antioxidants in ischemia-reperfusioninjury. Cardiovascular Research, 2000, 47, 446-456.
63. Suleiman, M. S.; Halestrap, A. P.; Griffiths, E. J. Mitochondria: A target for myocardial protection. Pharmacol. Ther., 2001, 89, 29-46. (Pubitemid 32367882)
64. Schwarz, E. R.; Whyte W. S.; Kloner, R. A.; Ischemic preconditioning. Curr. Opin. Cardiol., 1997, 12, 475-481. (Pubitemid 27417512)
65. Crisostomo, P. R.; Wairiuko, G. M.; Wang, M.; Tsai B. M.; Morrell, E. D.; Meldrum, D. R. Preconditioning versus postconditioning: Mechanismsand therapeutic potentials. J. Am. Coll. Surg., 2006, 202, 797-812.
66. Halestrap, A. P.; McStay, G. P.; Clarke, S. J. The permeability transition pore complex: Another view. Biochimie., 2002, 84, 153-166.
67. Bernardi, P.; Krauskopf, A.; Basso, E.; Petronilli, V.; BlalchyDyson, E.; DiLisa, F.; Forte, M. A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J., 2006, 273, 2077-2099.
68. Halestrap, A. A pore way to die. Nature, 2005, 434, 578-579.
69. Waldmeier, P. C.; Zimmermann, K.; Qian T.; Tintelnot-Blomley, M.; Lemasters, J. J. Cyclophilin D as a drug target. Curr. Med. Chem., 2003, 10, 1485-1506. (Pubitemid 36896552)
70. Basso, E.; Fante, L.; Fowlkes, J.; Petronilli, V.; Forte, M. A.; Bernardi, P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J. Biol. Chem., 2005, 280, 18558-18561. (Pubitemid 41379552)
71. Nakagawa, T.; Shimizu, S.; Watanabe, T.; Yamaguchi, O.; Otsu, K.; Yamagata, H.; Inohara, H.; Kubo, T.; Tsujimoto, Y. Cyclophilin Ddependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 2005, 434, 652-658. (Pubitemid 40488558)
72. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 2005, 434, 658-662. (Pubitemid 40488559)
73. Halestrap, A. P.; Davidson, A. M. Inhibition of Ca2+-induced large amplitude swelling of liver and heart mitochondria by Cyclosporin A is probably caused by the inhibitor binding to mitochondrial matrix peptidylprolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J., 1990, 268, 153-160. (Pubitemid 20166664)
74. Griffiths, E. J.; Halestrap, A. P. Further evidence that cyclosporin-A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase-Implications for the immunosuppressive and toxic effects of cyclosporine. Biochem. J, 1991, 274, 611-614.
75. Connern, C. P.; Halestrap, A. P. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem. J., 1992, 284, 381-385.
76. Woodfield, K. Y.; Price, N. T.; Halestrap, A. P. cDNA cloning of rat mitochondrial cyclophilin. Biochim. Biophys. Acta, 1997, 1351, 27-30. (Pubitemid 27117464)
77. Kokoszka, J. E.; Waymire, K. G.; Levy, S. E.; Sligh, J. E.; Cai, J.; Jones, D. P.; et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 2004, 427, 461-465. (Pubitemid 38168501)
78. Baines, C. P.; Kaiser, R. A.; Sheiko, T.; Craigen, W. J; Molkentin, J. D. Voltage-dependent anion channels are dispensable for mitochondrialdependent cell death. Nat. Cell Biol., 2007, 9, 550-555. (Pubitemid 46696536)
79. Leung, A. W. C.; Varanyuwatana, P; Halestrap, A. P. The mitochondrial phosphate carrier interacts with cyclophilin D and my play a key role in the permeability transition. J. Biol. Chem., 2008, 283, 26312-26323.
80. Halestrap, A. P. What is the mitochondrial permeability transition pore? J. Mol. Cell Cardiol., 2009, 46, 821-831.
81. Forbes, R. A.; Steenbergen, C.; Murphy, E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ. Res., 2001, 88, 802-9. (Pubitemid 32429976)
82. Murata, M.; Akao, M.; O'Rourke, B.; Marban, E. Mitochondrial ATPsensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: Possible mechanism of cardioprotection. Circ. Res., 2001, 89, 891-98. (Pubitemid 34627894)
83. Borutaite, V.; Brown, G. C. Mitochondria in apoptosis of ischemic heart. FEBS Letters, 2003, 541, 1-5. (Pubitemid 36428907)
84. Zong, W. X.; Thompson, C. B. Necrotic death as a cell fate. Genes Dev., 2006, 20, 1-15. (Pubitemid 43042662)
85. Imahashi, K.; Schneider, M. D.; Steenbergen, C.; Murphy, E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res., 2004, 95, 734-41. (Pubitemid 39331934)
86. Murphy, E.; Steenbergen, C. Preconditioning: The mitochondrial connection. Annu. Rev. Physiol. , 2007, 69, 51-67. (Pubitemid 46457635)
87. Lemasters, J. J. V. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis. American Journal of Physiology, 1999, 276 (1 Pt 1), G1-G6.
88. Huang, J.; Klionsky, D. J. Autophagy and human disease. Cell Cycle, 2007, 6, 1837-1849. (Pubitemid 47327901)
89. Scherz-Shouval, R.; Shvets, E.; Fass, E.; Shorer, H.; Gil, L.; Elazar, Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J., 2007, 26, 1749-1760. (Pubitemid 46624042)
90. Choi, C. H; Jung, Y. K.; Oh, S. H. Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signalregulated mitogen-activated proteinkinases and retards cell death by suppressing endoplasmic reticulum stress-mediatedapoptosis. Mol. Pharmacol., 2010, 78, 114-125.
91. Demetris, A. J.; Adeyi, O.; Bellamy, C. O.; Clouston, A.; Charlotte F.; et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology, 2006, 44, 489-501. (Pubitemid 44214890)
92. Arkadopoulos, N.; Kostopanagiotou, G.; Theodoraki, K.; Farantos, C.; Theodosopoulos, T.; Stafyla, V.; et al. Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. World J. Surg., 2009, 33, 1909-1915.
93. Mosbah, I. B.; Alfany-Fernandez, I.; Martel, C.; Zaouali, M. A.; Bintanel-Morcillo, M.; Rimola, A.; et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death and Dis., 2010, 1 (e52), 1-12.
94. Grattagliano, I.; Vendemiale, G.; Lauterburg, B. H. Reperfusion injury of the liver: Role of mitochondria and protection by glutathione ester. Journal of Surgical Research., 1999, 86 (1), 2-8. (Pubitemid 29418480)
95. Metzger, J.; Dore S. P.; Lauterburg, B. H. Oxidant stress during reperfusion of ischemic liver: No evidence for a role of xanthine oxidase. Hepatology, 1988, 8 (3), 580-584.
96. Jaeschke, H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chemico-Biological Interactions, 1991, 79 (2), 115-136.
97. Fernandez, L.; Heredia, N.; Grande, L.; Gomez, G.; Rimola, A.; Marco, A.; Gelpi, E.; Rosello-Catafau, J.; Peralta, C. Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase. Hepatology, 2002, 36 (3), 562-572. (Pubitemid 34977166)
98. Jeon, B. R.; Yeom, D. H.; Lee, S. M. Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. Shock, 2001, 15 (2), 112-117.
99. Mochida, S.; Arai, M.; Ohno, A.; Masaka, N.; Ogata, I.; Fujiwara, K. Oxidative stress in hepatocytes and stimulatory state of Kupffer cells after reperfusion differ between warm and cold ischemia in rats. Liver, 1994, 14 (5), 234-240. (Pubitemid 24319991)
100. Nussler, A. K.; Di S. M.; Billiar, T. R.; et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med., 1992, 176 (1), 261-4.
101. Chung, H. T.; Pae, H. O.; Choi, B. M.; Billiar, T. R., Kim, Y. M. Nitric oxide as a bioregulator of apoptosis. Biochemical and Biophysical Research Communications, 2001, 282 (5), 1075-1079.
102. Peralta, C.; Rull, R.; Rimola, A.; Deulofeu, R.; Rosello-Catafau, J.; Gelpi, E.; Rodes, J. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation, 2001, 71 (4), 529-536. (Pubitemid 32207204)
103. Bradham, C. A.; Plumpe, J.; Manns, M. P.; Brenner, D. A.; Trautwein, C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. American Journal of Physiology, 1998, 275 (3 Pt 1), G387-G392.
104. Aggarwal, B. B. Tumour necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Annals of the Rheumatic Diseases., 2000, 59 (Suppl 1), i6-i16.
105. Diehl, A. M. Cytokine regulation of liver injury and repair. Immunological Reviews, 2000, 174, 160-171. (Pubitemid 30201387)
106. Peralta, C.; Prats, N.; Xaus, C.; Gelpi, E.; Rosello-Catafau, J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology, 1999, 30 (6), 1481-1489.
107. Teoh, N. C.; Farell, G. C. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. Journal of Gastroenterology and Hepatology, 2003, 18 (8), 891-902. (Pubitemid 37056167)
108. Wang L.; Du F.; Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell., 2008, 16; 133(4), 693-703. (Pubitemid 351636305)
109. Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol Hepatol. , 2007, 22 Suppl 1, S43-4. (Pubitemid 46848989)
110. Badiola, N.; Malagelada, C.; Llecha, N.; Hidalgo, J.; Comella, J. X.; Sabriá, J.; Rodríguez-Alvarez, J. Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygenglucose deprived cultured cortical cells. Neurobiol. Dis., 2009, 35(3), 438-447.
111. Yoshidome, H.; Kato, A.; Edwards, M. J.; Lentsch, A. B. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor kappa B. Hepatology, 1999, 30 (1), 203-208. (Pubitemid 29300587)
112. Bradham, C. A.; Schemmer, P.; Stachlewitz, R. F.; Thurman, R. G.; Brenner, D. A. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transplantation and Surgery, 1999, 5 (4), 282-293. (Pubitemid 29321247)
113. Lieber, A.; He, C. Y.; Meuse, L.; Schowalter, D.; Kirillova, I.; Winther, B.; Kay, M. A. The role of Kupffer cell activation and viral gene expression inearly liver toxicity after infusion of recombinant adenovirus vectors. Journal of Virology, 1997, 71 (11), 8798-8807 (Pubitemid 27446464)
114. Iimuro, Y.; Nishiura, T.; Hellerbrand, C.; Behrns, K. E.; Schoonhoven, R.; Grisham, J. W.; Brenner, D. A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. Journal of Clinical Investigation, 1998, 101 (4), 802-811. (Pubitemid 28096077)
115. Caraceni, P.; Nardo, B.; Domenicali, M.; Turi, P.; Vici, M.; Simoncini, M.; De Maria, N.; Trevisani, F.; Van Thiel, D. H.; Derenzini, M.; Cavallari, A.; Bernardi, P. Ischemia-reperfusion injury in rat fatty liver: Role of nutritional status. Hepatology, 1999, 29(4), 1139.
116. Hakamada, K.; Sasaki, M.; Takahashi, K.; Umehara, Y.; Konn, M. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. Journal of Surgical Research, 1997, 70 (1), 12-20. (Pubitemid 27300645)
117. Sun, C. K.; Zhang, X. Y.; Zimmermann, A.; Davis, G.; Wheatley, A. M. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation, 2001, 27, 72(10):1625-31. (Pubitemid 33096735)
118. Clemens, M. G.; Zhang, J. X. Regulation of sinusoidal perfusion: In vivo methodology and control by endothelins. Semin. Liver Dis., 1999, 19, 383-96. (Pubitemid 30032640)
119. Mosher, B.; Dean, R.; Harkema, J.; Remick, D.; Palma, J.; Crockett, E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J. Surg. Res. , 2001, 99(2), 201-10. (Pubitemid 32703438)
120. Fukumori, T.; Ohkohchi, N.; Tsukamoto, S.; Satomi, S. Why is a liver with steatosis susceptible to cold ischemic injury? Transplant Proc. , 1999, 31(1-2), 548-9. (Pubitemid 29127568)
121. Cutrin, J. C.; Perrelli, M. G.; Cavalieri, B.; Peralta, C.; Rosello-Catafau, J.; Poli, G. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radical Biology and Medicine., 2002, 33 (9), 1200-1208. (Pubitemid 35246588)
122. Banga, N. R.; Homer-Vanniasinkam, S.; Graham, A.; Al-Mukhtar, A.; White, S. A.; Prasad, K. R. Ischaemic preconditioning in transplantation and major resection of the liver. British Journal of Surgery, 2005, 92 (5), 528-538. (Pubitemid 40685646)
123. Caldwell-Kenkel, J. C.; Currin, R. T.; Tanaka, Y.; Thurman, R. G.; Lemasters, J. J. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology, 1991, 13 (1), 83-95.
124. McCuskey, R. S.; Urbaschek, R.; Urbaschek, B. The microcirculation during endotoxemia. Cardiovascular Research., 1996, 32 (4), 752-763. (Pubitemid 26332314)
125. Peralta, C.; Fernandez, L.; Panes, J.; Prats, N.; Sans, M.; Pique, J. M.; Gelpi, E.; Rosello-Catafau, J. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology, 2001, 33, (1), 100-113. (Pubitemid 32016892)
126. Vendemiale, G.; Grattagliano, I.; Caraceni, P.; Caraccio, G.; Domenicali, M.; Dall'Agata, M.; et al. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: Effect of the nutritional status. Hepatology, 2001, 33, 808-815. (Pubitemid 32246628)
127. Caraceni, P.; Bianchi, C.; Domenicali, M.; Maria Pertosa, A.; Maiolini, E.; Parenti, Castelli G.; et al. Impairement of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury. J. Hepatol., 2004, 41, 82-88. (Pubitemid 39005157)
128. Lanir, A.; Jenkins, R. L.; Caldwell, C.; Lee, R. G.; Khettry, U.; Clouse, M. E. Hepatic transplantation survival: Correlation with adenine nucleotide level in donor liver. Hepatology. 1988, 8, 471-475.
129. Marni, A.; Ferrero, M. E.; Gaja, G. Metabolic function of grafted liver in rats. Transplantation, 1988, 46, 830-835. (Pubitemid 19013226)
130. Chavin, K. D.; Yang, S.; Lin, H. Z.; Chatham, J.; Chacko, V. P.; Hoek, J. B.; Walajtys-Rode, E.; Rashid, A.; Chen, C. H.; Huang, C. C.; Wu, T. C.; Lane, M. D.; Diehl, A. M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem., 1999, 274, 5692-5700. (Pubitemid 29109222)
131. Ke, B.; Lipshutz G. S.; Kupiec-Weglinski, J. W. Gene therapy in liver ischemia and reperfusion injury. Curr. Pharm. Des., 2006, 12, 2969-2975. (Pubitemid 44184629)
132. Mari, M.; Bai J.; Cederbaum, A. I. Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP2E1. Journal of Pharmacology and Experimental Therapeutics, 2002, 301(1), 111-118. (Pubitemid 34250286)
133. Selzner, N.; Rudiger, H.; Graf, R.; Clavien, P. A. Protective strategies against ischemic injury of the liver. Gastroenterology, 2003, 125 (3), 917-936. (Pubitemid 37070708)
134. Coito, A. J.; Buelow, R.; Shen, X. D.; Amersi, F.; Moore, C.; Volk, H. D.; Busuttil, R. W.; Kupiec-Weglinski, J. W. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation, 2002, 74 (1), 96-102. (Pubitemid 34779218)
135. Harada, H.; Wakabayashi, G.; Takayanagi, A.; Shimazu, M.; Matsumoto, K.; Obara, H.; Shimizu, N.; Kitajima, M. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury. Transplantation, 2002, 74 (10), 1434-1441. (Pubitemid 35379551)
136. Pachori, A. S.; Melo, L. G.; Hart, M. L.; Noiseux, N.; Zhang, L.; Morello, F.; Solomon, S. D.; Stahl, G. L.; Pratt, R. E.; Dzau, V. J. Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proceedings of the National Academy of Sciencesof the United States of America., 2004. 101 (33), 12282-12287. (Pubitemid 39145435)
137. Lentsch, A. B.; Kato, A.; Yoshidome H.; McMasters K. M.; Edwards M. J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology, 2000, 32 (2), 169-173. (Pubitemid 30614647)
138. Li, X.; Zhang, J. F.; Lu, M. Q.; Yang, Y.; Xu, C.; Li, H.; Wang, G. S.; Cai, C. J.; Chen, G. H. Alleviation of ischemia-reperfusion injury in rat liver transplantation by induction of small interference RNA targeting Fas. Langenbecks Arch. Surg., 2007, 392(3), 345-51. (Pubitemid 46675799)
139. Varela, A. T.; Simões, A. M.; Teodoro, J. S.; Duarte, F. V.; Gomes, A. P.; Palmeira, C. M.; Rolo, A. P. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition. Mitochondrion., 2010, 10(5), 456-63.
140. Serafín, A.; Fernández-Zabalegui, L.; Prats, N.; Wu, Z. Y.; Roselló-Catafau, J.; Peralta, C. Ischemic preconditioning: Tolerance to hepatic ischemiareperfusion injury. Histol. Histopathol, 2004, 19(1), 281-289. (Pubitemid 38111271)
141. Peralta, C.; Hotter, G.; Closa, D.; Prats, N.; Xaus, C.; Gelpí, E.; Roselló-Catafau, J. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology, 1999, 29, 126-132. (Pubitemid 29023994)
142. Carini, R.; Grazia De Cesaris, M.; Splendore, R.; Domenicotti, C.; Nitti, M. P.; Pronzato, M. A.; Albano, E. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic. Biol. Med., 2003, 34, 1047-1055. (Pubitemid 36398564)
143. Morihira, M.; Hasebe, N.; Baljinnyam, E.; Sumitomo, K.; Matsusaka, T.; Izawa, K.; Fujino, T.; Fukuzawa, J.; Kikuchi, K. Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size. Am. J. Physiol., 2006, 290 H577-H583.
144. Bolli, R. The late phase of preconditioning. Circ. Res., 2000, 87, 972-983.
145. Teoh, N.; Leclercq, I.; Pena, A. D.; Farell, G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: Implications for preconditioning. Hepatology, 2003, 37 (1), 118-128. (Pubitemid 36042152)
146. Inagaki, K.; Churchill, E.; Mochly, Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc. Res., 2006, 70, 222-230.
147. Ye, S. Y.; Wu, J.; Zhang, J.; Zheng, S. S. Locally synthesized HSP27 in hepatocytes: Is it possibly a novel strategy against human liver ischemia/reperfusion injury? Med. Hypotheses., 2011, 76(2), 296-8.
148. Saito, T.; Ishii, S.; Abe, T.; Tsuchiya, T.; Kanno, H.; Miyazawa, M.; Suzuki, M.; Gotoh, M. Effect of preconditioning in the liver against alterations of gene transcription. Transplant. Proc., 2001, 33, 849.
149. Hafez, T. S.; Glantzounis, G. K.; Fusai, G.; Taanman, J. W.; Wignarajah, P.; Parkes, H.; Fuller, B.; Davidson, B. R.; Seifalian, A. M. Intracellular oxygenation and cytochrome oxidase C activity in ischemic preconditioning of steatotic rabbit liver. Am. J. Surg., 2010, (4), 507-18.
150. Kockeritz, L.; Doble, B.; Patel, S.; Woodgett, J. R. Glycogen Synthase Kinase-3-An overview of an over-achieving protein kinase. Curr. Drug Targets, 2006, 7, 1377-1388. (Pubitemid 44718298)
151. Matsui, T.; Rosenzweig, A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: The role of PI 3-kinase and Akt. J. Mol. Cell Cardiol., 2005, 38, 63-71. (Pubitemid 40038652)
152. Bijur, G. N.; Jope, R. S. Rapid accumulation of Akt in mitochondria following phosphatidyl-inositol 3-kinase activation. J. Neurochem, 2003, 87, 1427-1435. (Pubitemid 38020576)
153. Miyamoto, S.; Murphy, A. N.; Brown, J. H. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II, Cell Death Differ., 2008, 15, 521-529. (Pubitemid 351267303)
154. Chen, H.; Xing, B.; Liu, X.; Zhan, B.; Zhou, J.; Zhu, H.; Chen, Z. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transpl. Int., 2008, 21, 364-371. (Pubitemid 351348006)
155. Sinay, L.; Kurthy, M.; Horvath, S.; Arato, E.; Shafei, M.; Lantos, J.; Ferencz, S.; Bator, A.; Balatonyi, B.; Verzar, Z.; Suto, B.; Kollar, L.; Weber, G.; Roth, E.; Jancso, G. Ischaemic postconditioning reduces peroxide formation, cytokine expression and leukocyte activation in reperfusion injury after abdominal aortic surgery in rat model. Clin. Hemorheol. Microcirc., 2008, 40, 133-142.
156. Wang, J. Y.; Shen, J.; Gao, Q.; Ye, Z. G.; Yang, S. Y.; Liang, H. W.; Bruce, I. C.; Luo, B. Y.; Xia, Q. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke, 2008, 39, 983-990. (Pubitemid 351619573)
157. Xing, B.; Chen, H.; Zhang, M.; Zhao, D.; Jiang, R.; Liu, X.; Zhang, S. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke, 2008, 39, 2362-2369.
158. Zeng, Z.; Huang, H. F.; Chen, M. Q.; Song, F.; Zhang, Y. J. Postconditioning Prevents Ischemia/Reperfusion Injury in Rat Liver Transplantation. Hepatogastroenterology, 2010, 57(101), 875-81
159. Chen, D. H.; Xie J. X. Chinese Traditional Herb. Drugs, 1984, 15, 6.
160. Meijer, L.; Skaltsounis, A. L.; Magiatis, P.; Polychronopoulos, P.; Knockaert, M.; Leost, M.; Ryan, X. P.; Vonica, C. A.; Brivanlou, A.; Dajani, R.; Crovace, C. Tarricone, C.; Musacchio, A.; Roe, S. M.; Pearl, L.; Greengard, P. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol., 2003 , 1255-66. (Pubitemid 38050973)
161. Jope, R. S.; Roh, M. S. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets., 2006 , 1421-34. (Pubitemid 44718302)
162. Barillas, R.; Friehs, I.; Cao-Danh, H.; Martinez, J. F.; del Nido, P. J. Inhibition of glycogen synthase kinase-3 beta improves tolerance to ischemia in hypertrophied hearts. Ann. Thorac. Surg., 2007 , 126-33. (Pubitemid 46921104)
163. Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.; Brivanlou, A. H.; Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signalling by a pharmacological GSK-3-specific inhibitor. Nat. Med., 2004. 10, 55-63. (Pubitemid 38524699)
164. Zhan, N.; Jiang, Y.; Zou, J.; Zhang, B.; Jin, H.; Wang, Y.; Yu, Q. 3D QSAR for GSK3beta inhibition by indirubin analogues. Eur. J. Med. Chem., 2006, 41(3), 373-8.
165. Doble, B. W.; Woodgett, J. R. GSK-3: Tricks of the trade for a multi-tasking kinase. J. Cell Sci., 2003, 116, 1175-1186. (Pubitemid 36410657)
166. Tong, H.; Imahashi, K.; Steenbergen, C.; Murphy, E. Phosphorylation of glycogen synthase kinase-3b beta during preconditionoing through a phosphatidylinositol-3-kinase dependent pathway is cardioprotective. Circ. Res., 2002, 90, 377-379. (Pubitemid 34633905)
167. Gross, E. R.; Hsu, A. K.; Fross, G. J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta during reperfusion in intact rat hearts. Circ. Res., 2004, 94, 960-966. (Pubitemid 38490074)
168. Pagel, P. S.; Krolikowski, J. G.; Neff, D. A.; Weihrauch, D.; Bienengraeber, M.; Kersten, J. R.; Wartlier, D. C. Inhibition of glycogen synthase kinases enhances isoflurane-induced protetion against myocardial infarction during early reperfusion in vivo. Anesth. Analg., 2006, 102, 1348-1354.
169. Gomez, L.; Paillard, M.; Thibault, H.; Derumeauz, G.; Ovize, M. Inhibition of GSK3-beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation., 2008, 117, 2761-2768. (Pubitemid 351770456)
170. Juhaszova, M.; Wang, S.; Zorov, D. B.; Nuss, H. B.; Gleichmann, M.; Mattson, M. P.; Sollott, S. J. The identity and regulation of the mitochondrial permeability transition pore: Where the known meets the unknown. Ann. N. Y. Acad. Sci., 2008, 1123, 197-212. (Pubitemid 351431318)
171. Nishihara, M.; Miura, T.; Miki, T.; Tanno, M.; Yano, T.; Naitoh, K.; et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3-mediated myocardial protection. J. Mol. Cell Cardiol., 2007, 43, 564-570. (Pubitemid 47615050)
172. Pastorino, J. G.; Hoek, J. B.; Shulga, N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res., 2005, 65, 10545-10554. (Pubitemid 41743749)
173. Xi, J.; Wang, H.; Mueller, R. A.; Norfleet, E. A.; Xu, Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur. J. Pharmacol., 2009, 604(1-3), 111-6.
174. Hausenloy, D. J.; Maddock, H. L.; Baxter, G. F.; Yellon, D. M. Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning? Cardiovasc. Res., 2002, 55, 534-43. (Pubitemid 34874948)
175. Argaud, L.; Loufouat, J.; Gateau-Roesch, O.; Gomez, L.; Robert, D.; Ovize, M. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion. Shock, 2008, 28, 28.
176. Gateau-Roesch, O.; Argaud, L.; Ovize, M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc. Res., 2006, 70, 264-73.
177. Argaud, L.; Gateau-Roesch, O.; Raisky, O.; Loufouat, J.; Robert, D.; Ovize, M. Postconditioning inhibits mitochondrial permeability transition. Circulation., 2005, 111, 194-7. (Pubitemid 40139731)
178. Jaburek, M.; Costa, A. D. T.; Burton, J. R.; Costa, C. L.; Garlid, K. D. Mitochondrial PKC-epsilon and mitoKATP co-purify and co-reconstitute to form a functioning signaling module in proteoliposomes. Circ. Res., 2006, 99, 878-83. (Pubitemid 44556387)
179. Costa, A. D. T.; Garlid, K. D. Intramitochondrial signaling: Interactions among mito KATP, PKC , ROS, and MPT. Am. J. Physiol., 2008, 295, H874-82.
180. Costa, A. D.; Jakob, R.; Costa, C. L.; Andrukhiv, K.; West, I. C.; Garlid, K. D. The mechanism by which mitoKATP opening and H2O2 inhibit the mitochondrial permeability transition. J. Biol. Chem., 2006, 281, 20801-8.
181. Andrukhiv, A.; Costa, A. D.; West, I. C.; Garlid, K. D. Opening mitoKATP increases superoxide generation from Complex I of the electron transport chain. Am. J. Physiol., 2006, 291, H2067-2074.
182. Huet, P. M.; Nagaoka, M. R.; Desbiens, G.; et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-arm reperfusion of the rat liver. Hepatology, 2004, 39, 1110.
183. Wu, Q.; Tang, C.; Zhang, Y. J.; Jiang, Y.; Li, X. W.; Wang, S. G.; Bie, P. Diazoxide Suppresses Hepatic Ischemia/Reperfusion Injury After Mouse Liver Transplantation by a BCL-2-Dependent Mechanism. J. Surg. Res., 2010.
184. Stein, S. C.; Woods, A.; Jones, N. A.; Davison, M. D.; Carling, D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J., 2000, 345, 437-443. (Pubitemid 30099070)
185. Ben Mosbah, I.; Massip-Salcedo, M.; Fernández-Monteiro, I.; Xaus, C.; Bartrons, R.; Boillot, O.; Roselló-Catafau, J.; Peralta, C. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: A way of protecting rat steatotic livers. Liver Transpl. , 2007, 13(3), 410-25. (Pubitemid 46444471)
186. Gao, D.; Ning, D.; Niu, X.; Hao, G.; Meng, Z. Trimetazidine: A metaanalysis of randomised controlled trials in heart failure. Heart, 2011, 97(4), 278-86.
187. Bertomeu-Gonzalez, V.; Bouzas-Mosquera, A.; Kaski JC. Role of trimetazidine in management of ischemic cardiomyopathy. Am. J. Cardiol, 2006, 98:19J-24J.
188. Onay-Besikci, A.; Ozkan, S. A. Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine. Cardiovasc. Ther., 2008, 26:147-65. (Pubitemid 351945127)
189. Park, K. H.; Park, W. J.; Kim M. K.; et al. Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery. Am. J. Cardiol., 2010, 105:1723-1727.
190. Khan, M.; Meduru, S.; Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J. Pharmacol. Exp. Ther., 2010, 333:421-429.
191. Yin, R. X.; Liang, W. W.; Liu T. W.; et al. Inhibitory effect of trimetazidine on cardiac myocyte apoptosis in rabbit model of ischemia-reperfusion. Chin. Med. Sci. J., 2004, 19:242.
192. Wisel, S.; Khan, M.; Kuppusamy, M. L.; et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2, 3, 4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J. Pharmacol. Exp. Ther., 2009, 329:543-50.
193. Hauet, T.; Bauza, G.; Goujon, J. M.; Caritez, J. C.; Carretier, M.; Eugene, M.; Tillement, J. P. Effects of trimetazidine on lipid peroxidation and phosphous metabolites during cold storage and reperfusion of isolated perfused rat kidneys. Journal of Pharmacology and Experimental Therapeutics, 1998, 285 (3), 1061-1067. (Pubitemid 28277904)
194. Elimadi, A.; Sapena, R.; Settaf, A.; Le Louet, H.; Tillement, J. P.; Morin, D. Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial function with S-15176, a potent trimetazidine derivative. Biochemical Pharmacology, 2001, 62 (4), 509-516. (Pubitemid 32607734)
195. Ikizler, M.; Dernek, S.; Sevin, B.; Kural, T. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia. Anadolu Kardiyoloji Dergisi, 2003, 3 (4), 303-308. (Pubitemid 38016602)
196. Monti, L. D.; Allibardi, S.; Piatti, P. M.; Valsecchi, G.; Costa, S.; Pozza, G.; et al. Triglycerides impair postischemic recovery in isolated hearts: Roles of endothelin-1 and trimetazidine. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, 1122-1130.
197. Carrasco-Chaumel, E.; Rosello-Catafau, J.; Bartrons, R.; Franco-Gou, R.; Xaus C.; Casillas, A.; Gelpi, E.; Rodes, J.; Peralta, C. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. Journal of Hepatology, 2005, 43 (6), 997-1006. (Pubitemid 41627985)
198. Ben Mosbah, I.; Massip-Salcedo, M.; Fernández-Monteiro, I.; Xaus, C.; Bartrons, R.; Boillot, O.; Roselló-Catafau, J.; Peralta, C. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: A way of protecting rat steatotic livers. Liver Transpl. , 2007, 13(3), 410-25. (Pubitemid 46444471)
199. Carini, R.; De Cesaris, M. G.; Splendore, R.; Vay, D.; Domeni-cotti, C.; Nitti, M. P.; et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology, 2001, 33, 131-139. (Pubitemid 32016895)
200. Nakayama, H.; Yamamoto, Y.; Kume, M.; Yamagami, K.; Yamamoto, H.; Kimoto, S.; et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery, 1999, 126, 945-954. (Pubitemid 29523335)
201. Dal Ponte, C.; Alchera, E.; Follenzi, A.; Imarisio, C.; Prat, M.; Albano, E.; Carini, R. Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury. Liver Transpl., 2011, 17(4), 474-82.
202. Timmermans, P. B.; Carini, D. J.; Chiu, A. T.; Duncia, J. V.; Price, W. A. Jr.; Wells, G. J.; Wong, P. C.; Johnson, A. L.; Wexler, R. R. The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonists. Am. J. Hypertens. 1991. 275-281.
203. Wong, P. C.; Hart, S. D.; Zaspel, A. M.; Chiu, A. T.; Ardecky, R. J.; Smith, R. D.; Timmermans, P. B. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753(AII-1) and PD123177 (AII 2). J. Pharmacol. Exp. Ther., 1990, 584-92.
204. Chiu, A. T.; Herblin, W. F.; McCall, D. E.; Ardecky, R. J.; Carini, D. J.; Duncia, J. V.; Pease, L. J.; Wong, P. C.; Wexler, R. R.; Johnson, A. L., et al. Identification of angiotensin II receptor subtypes. Biochem. Biophy. Res. Commun., 1989, 196-203 (Pubitemid 20012475)
205. Chiu, A. T.; McCall, D. E.; Aldrich, P. E.; Timmermans, P. B. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem. Biophys. Res. Commun., 1990, 1195-202
206. Israili, Z. H. Clinical pharmacokinetics of angiotens in II (AT1) receptor blockers in hypertension. J. Hum. Hypertens., 2000, Suppl 1 : S73-86. (Pubitemid 30409970)
207. Ramalho, F. S.; Ramalho, L. N.; Castro-e-Silva Junior, O.; Zucoloto, S.; Correa, F. M. Effect of angiotensin converting enzyme inhibitors on liver regeneration in rats. Hepatogastroenterology, 2002, 49, 1347-1351.
208. Yayama, K.; Sugiyama, K.; Miyagi, R.; Okamoto H. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: Involvement of bradykinin B2 and angiotensin AT1 receptors. Biol. Pharm. Bull., 2007, 30, 591-594. (Pubitemid 46355936)
209. Casillas-Ramirez, A.; Amine-Zaouali, M.; Massip-Salcedo, M.; Padrissa-Altes, S.; Bintanel-Morcillo, M.; Ramalho, F.; Serafín, A.; Rimola, A.; Arroyo, V.; Rodes, J.; et al. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit. Care Med., 2008, 36, 1256-1266. (Pubitemid 351482676)
210. Shishido, S. M. Polyethylene glycol matrix reduces the rates of photochemical and thermal release of nitric oxide from S-nitroso- Nacetylcysteine. Photochem. Photobiol., 2000, 71(3)273-80.
211. Phillips, L.; Toledo, A. H.; Lopez-Neblina, F.; Anaya-Prado, R.; Toledo-Pereyra, L. H. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J. Invest. Surg., 2009, 22, 46-55
212. de Oliveira, C. P.; Simplicio, F. I.; de Lima, V. M.; Yuahasi, K.; Lopasso, F. P.; Alves, V. A.; et al. Oral administration of S-nitroso-N- acetylcysteine prevents the onset of non-alcoholic fatty liver disease in rats. World J. Gastroenterol 2006. 12:1905-11.
213. Scherer de Fraga, R.; Camacho, V. R.; Souza, G. F.; Cerski, C. T.; de Oliveira, J. R.; de Oliveira, M. G.; Álvares-da-Silva M. R. S-nitroso-Nacetylcysteine: A promising drug for early ischemia/reperfusion injury in rat liver. Transplant Proc., 2010, 42(10), 4491-5.
214. Andraus, W.; de Souza, G. F.; de Oliveira, M. G.; Haddad, L. B.; Coelho, A. M.; Galvão, F. H.; Leitão, R. M.; D'Albuquerque, L. A.; Machado, M. C.; Snitroso-N-acetylcysteine ameliorates ischemia-reperfusion injury in the steatotic liver. Clinics (Sao Paulo)., 2010, 65(7), 715-21.
215. Goto, S.; Kim, Y. I.; Kodama, Y.; Kai, T.; Kawano, K.; Delriviere, L.; Lynch, S. V.; Kamada, N.; Kobayashi, M. The effect of a prostaglandin I2 analogue (OP-41483) on energy metabolism in liver preservation and its relation to lipid peroxidative reperfusion injury in rats. Cryobiology, 1993, 30 (5), 459-465.
216. Anaise, D.; Ishimaru, M.; Madariaga, J.; Irisawa, A.; Lane, B.; Zeidan, B.; Sonoda, K.; Shabtai, M.; Waltzer, W. C.; Rapaport, F. T. Protective effects of trifluoperazine on themicrocirculation of cold-stored livers. Transplantation, 1990, 50(6), 933-939.
217. Moresco, R. N.; Santos, R. C.; Alves Filho, J. C.; Cunha, A. A.; dos Reis, C.; Reichel, C. L.; de Oliveira, J. R. Protective effect of fructose-1, 6 bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation. Transplantation Proceedings, 2004, 36 (5), 1261-1264. (Pubitemid 38902952)
218. Yoshinari, D.; Takeyoshi, I.; Kobayashi, M.; Koyama, T.; Iijima, K.; Ohwada, S.; Matsumoto, K.; Morishita, Y. Effects of a p38 mitogenactivated protein kinase inhibitor as an additive to University of Wisconsin solution on reperfusion injury in liver transplantation. Transplantation, 2001, 72 (1), 22-27. (Pubitemid 32652501)
219. Vajdova, K.; Graf, R.; Clavien, P. A. ATP-supplies in the cold-preserved liver: A long-neglected factor of organ viability. Hepatology, 2002, 36 (6), 1543-1552. (Pubitemid 35403546)
220. Takada, Y.; Boudjema, K.; Jaeck, D.; Bel-Haouari, M.; Doghmi, M.; Chenard, M. P.; Wolf, P.; Cinqualbre, J. Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. Transplantation, 1995, 59 (1), 10-16.
221. Rodriguez, J. V.; Guibert, E. E.; Quintana, A.; Scandizzi, A.; Almada, L. Role of sodium nitroprusside in the improvement of rat liver preservation in University of Wisconsin solution: A study in the isolated perfused liver model. Journal of Surgical Research., 1999, 87 (2), 201-208. (Pubitemid 30000587)
222. Li, X. L.; Man, K.; Liu, Y. F.; Lee, T. K.; Tsui, S. H.; Lau, C. K.; Lo, C. M.; Fan, S. T. Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation. Transplantation, 2003, 76 (1), 44-49. (Pubitemid 36877113)
223. Hausenloy, D. J.; Yellon, D. M. New directions for protecting the heart against ischemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovascular Research, 2004, 61 (3), 448-460. (Pubitemid 38210151)
224. Casillas-Ramirez, A.; Zaouali, A.; Padrissa-Altes, S.; Ben Mosbah, I.; Pertosa, A.; Alfany-Fernandez, I.; et al. Insulin-like growth factor and epidermal growth factor treatment: New approaches to protecting steatotic livers against ischemia-reperfusion injury. Endocrinology, 2009, 150, 3153-3161.
225. Zaouali, M. A.; Padrissa-Altés, S.; Ben Mosbah, I.; Ben Abdennebi, H.; Boillot, O.; Rimola, A.; Saidane-Mosbahi, D.; Roselló-Catafau, J. Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J. Gastroenterol. , 2010, 16(45), 693-700.
226. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. , 2005, 434(7033), 658-62. (Pubitemid 40488559)
227. Miura, T.; Nishihara, M.; Miki, T. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: Role of GSK-3beta in myocardial protection against ischemia/reperfusion injury. J. Pharmacol. Sci. , 2009, 109(2), 162-7.
228. Shulga, N.; Wilson-Smith, R.; Pastorino, J. G. Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J. Cell. Sci., 2010, 123(Pt 6), 894-902.
229. Hafner, A. V.; Dai, J.; Gomes, A. P.; Xiao, C. Y.; Palmeira, C. M.; Rosenzweig, A.; Sinclair, D. A. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY). 2010, 2(12), 914-23.
230. Bao, J.; Scott Lu, Z.; Pang, L.; Dimond, C. C.; Gius, D.; Sack, M. N. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med., 2010, 49(7), 1230-7.
231. Kendrick, A. A.; Choudhury, M.; Rahman, S. M.; McCurdy, C. E.; Friederich, M.; Van Hove, J. L.; Watson, P. A.; Birdsey, N.; Bao, J.; Gius, D.; Sack, M. N.; Jing, E.; Kahn, C. R.; Friedman, J. E.; Jonscher, K. R. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. 2011, 433(3), 505-14